200 filings
Page 6 of 10
8-K
car8h65ej acq
13 Jun 14
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
NT 10-Q
9ayw5sjjtc5cp6
16 May 14
Notice of late quarterly filing
12:00am
8-K
3knzckq68x
14 May 14
Departure of Directors or Certain Officers
12:00am
8-K
cna ywzy8b
7 May 14
Departure of Directors or Certain Officers
12:00am
8-K
o7o40bs7mh897
5 May 14
Entry into a Material Definitive Agreement
12:00am
NT 10-K/A
wguhqb2t3 cgh9gadq
16 Apr 14
Notice of late annual filing (amended)
12:00am
8-K
xhaovru9b eqlgid
16 Apr 14
Results of Operations and Financial Condition
12:00am
NT 10-K
y3ttphks
1 Apr 14
Notice of late annual filing
12:00am
8-K
fna8i05cvctegub7c9
24 Mar 14
Emmaus Life Sciences Announces Positive Top-line Results of Its Phase 3 Clinical Trial for Sickle Cell Disease
12:00am
8-K
9m9ese8n ex
15 Jan 14
Changes in Registrant's Certifying Accountant
12:00am
8-K
vmwyq lzjhilh
31 Dec 13
Departure of Directors or Certain Officers
12:00am
D/A
f5k 27pn1z5j7
2 Oct 13
$7.55M in equity / options, sold $7.55M, 36 investors
12:00am
8-K
unseu
26 Sep 13
Submission of Matters to a Vote of Security Holders
12:00am
D
h847hu7bvrpl htb5sva
24 Sep 13
$7.55M in equity / options, sold $7.55M, 36 investors
12:00am
8-K
7oyi1v wc58k
17 Sep 13
Emmaus Life Sciences Announces Closing of $7.5 Million Private Placement
12:00am